Meta-analysis: diagnostic value of serum anti-mutated citrullinated vimentin antibodies in patients with rheumatoid arthritis (Q37707130)

22 August 2017

0 references

Meta-analysis: diagnostic value of serum anti-mutated citrullinated vimentin antibodies in patients with rheumatoid arthritis (English)

1 reference

22 August 2017

0 references

0 references

1 reference

1 reference

Xue Qin

1

1 reference

22 August 2017

Yan Deng

2

1 reference

22 August 2017

Jing Xu

3

1 reference

22 August 2017

Tai-Jie Li

4

1 reference

22 August 2017

Shan Li

5

1 reference

22 August 2017

Jin-Min Zhao

6

1 reference

22 August 2017

publication date

10 March 2010

1 reference

Rheumatology International

22 August 2017

published in

1 reference

22 August 2017

volume

31

1 reference

22 August 2017

issue

6

1 reference

22 August 2017

page(s)

785-794

1 reference

https://scigraph.springernature.com/pub.10.1007/s00296-009-1343-3

22 August 2017

exact match

0 references

cites work

Criteria for early rheumatoid arthritis: from Bayes' law revisited to new thoughts on pathogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS00296-009-1343-3

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-009-1343-3

Diagnostic value of anti-human citrullinated fibrinogen ELISA and comparison with four other anti-citrullinated protein assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-009-1343-3

The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-009-1343-3

Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-009-1343-3

Anti-CCP: history and its usefulness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-009-1343-3

The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-009-1343-3

Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-009-1343-3

Anti-cyclic citrullinated peptide positivity in non-rheumatoid arthritis disease samples: citrulline-dependent or not?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-009-1343-3

Anti-Sa antibodies: prognostic and pathogenetic significance to rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-009-1343-3

Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-009-1343-3

Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-009-1343-3

Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-009-1343-3

Conducting systematic reviews of diagnostic studies: didactic guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-009-1343-3

The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-009-1343-3

The diagnostic odds ratio: a single indicator of test performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-009-1343-3

Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-009-1343-3

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-009-1343-3

The conditional relative odds ratio provided less biased results for comparing diagnostic test accuracy in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-009-1343-3

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-009-1343-3

Technical and diagnostic performance of 6 assays for the measurement of citrullinated protein/peptide antibodies in the diagnosis of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-009-1343-3

Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-009-1343-3

Antibodies to mutated citrullinated vimentin and disease activity score in early arthritis: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-009-1343-3

Antibodies against citrullinated vimentin in rheumatoid arthritis: higher sensitivity and extended prognostic value concerning future radiographic progression as compared with antibodies against cyclic citrullinated peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-009-1343-3

Comparative performance analysis of 4 different anti-citrullinated protein assays in the diagnosis of rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-009-1343-3

Potential for altering rheumatoid arthritis outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-009-1343-3

Systematic reviews in health care: Systematic reviews of evaluations of diagnostic and screening tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-009-1343-3

Guidelines for meta-analyses evaluating diagnostic tests.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-009-1343-3

Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-009-1343-3

Approaches to heterogeneity in meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-009-1343-3

Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis

21 January 2018

1 reference

12 December 2020

Antibodies to citrullinated vimentin are a specific and sensitive marker for the diagnosis of rheumatoid arthritis

1 reference

12 December 2020

Anticyclic citrullinated peptide antibodies in patients with mixed connective tissue disease

1 reference

12 December 2020

Patients with rheumatoid arthritis benefit from early 2nd line therapy: 5 year followup of a prospective double blind placebo controlled study

1 reference

12 December 2020

The Sa system: a novel antigen-antibody system specific for rheumatoid arthritis

1 reference

12 December 2020

Antibodies against mutated citrullinated vimentin are a better predictor of disease activity at 24 months in early rheumatoid arthritis than antibodies against cyclic citrullinated peptides

1 reference

12 December 2020

Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States

1 reference

12 December 2020

Longterm mortality outcome in patients with rheumatoid arthritis: early presenters continue to do well.

1 reference

12 December 2020

The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues

1 reference

12 December 2020

Value of laboratory tests in early prediction of rheumatoid arthritis

1 reference

12 December 2020

Analytical and diagnostic characteristics of 11 2nd- and 3rd-generation immunoenzymatic methods for the detection of antibodies to citrullinated proteins

1 reference

12 December 2020

Antibody against mutated citrullinated vimentin: a new sensitive marker in the diagnosis of rheumatoid arthritis

1 reference

12 December 2020

Value of antibodies to citrulline-containing peptides for diagnosing early rheumatoid arthritis

1 reference

12 December 2020

10.1007/S00296-009-1343-3

Identifiers

DOI

1 reference

22 August 2017

1 reference